Mydecine To Spin-Out Its U.S. Cannabis Assets By Mid July

Psychedelics and mycology company, Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE:0NFA), is seeking to increase shareholders value by spinning off its U.S. assets and its stake in U.S. cannabis projects into a newly formed subsidiary. 

The Denver-based company intends to spin off its holdings of common shares in the subsidiary to its shareholders.

In June 2020 Joshua Bartch, Mydecine's CEO, told they were looking for the best way to manage the company's cannabis properties.

"We're looking at what's the best positioning …

Full story available on Benzinga.com

More Mydecine To Spin-Out Its U.S. Cannabis Assets By Mid July